Impact Assessment of the Jockey Club REACH & Map Program for Hard-to-reach Older Adults

December 12, 2025 updated by: Prof. Yu, Doris Sau Fung, The University of Hong Kong

Impact Assessment of the Jockey Club REACH & Map Program for Hard-to-reach Older Adults in the Community: A Target Trial Emulation

The goal of this study is to evaluate the impact of the Reach-and-Map project on increasing functional capacity to optimize the functional ability of the vulnerable group of "Hard-to-Reach" older adults through increase the compatibility between their intrinsic capacity and environment.

Study Overview

Status

Recruiting

Detailed Description

The overall aim of this project is to conduct a comprehensive impact assessment of the Jockey Club (JC) Reach & Map Program, utilizing a framework based on the World Health Organization (WHO) Health Impact Assessment. The study will evaluate how the program influences health outcomes among hard-to-reach older adults by assessing changes in key health determinants. The findings will be disseminated to relevant stakeholders to inform future policy setting and service planning, and long-term monitoring will be undertaken to evaluate the extent to which the impact assessment influences decision-making in aged care service development.

The primary focus of the evaluation is on the functional abilities of older adults, including physical, cognitive, psychological, and social functioning. The assessment will also cover core outcomes such as quality of life, frailty, and health service use, alongside person-centered measures like loneliness and mental health. Given the diverse services received by beneficiaries, the study will account for structural and social health determinants-such as age, gender, socio-economic status, and chronic disease burden-as covariates in the analysis. In addition, the project will explore the broader effects of the JC Reach & Map Program on aged care service utilization and document both the experiences of service recipients and stakeholders involved.

Specifically, the study objectives are: (1) to evaluate the impact of the JC Reach & Map Program on frailty, quality of life, and health service use among hard-to-reach older adults, focusing on physical, cognitive, psychological, and social functions; (2) to explore the engagement experiences and perceptions of older adults regarding the services received, and their impact on well-being, community engagement, and social integration; and (3) to explore the experiences of service stakeholders in reaching and working with this population, as well as to gather their insights on ideal service models and policies for hard-to-reach older adults.

Study Type

Interventional

Enrollment (Estimated)

5500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Doris Sau Fung YU, PhD
  • Phone Number: 852-3917-6319
  • Email: dyu1@hku.hk

Study Locations

      • Hong Kong, Hong Kong
        • Recruiting
        • The University of Hong Kong
        • Contact:
          • Doris Sau Fung Prof. Yu,
          • Phone Number: +852 39176319
          • Email: dyu1@hku.hk
        • Principal Investigator:
          • Doris Sau Fung Prof. Yu,

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • age > 60
  • able to participate in the impact assessment as evidence by a test score of > 6 on the Abbreviated Mental Test
  • has the functional ability to engage in the digital intervention
  • able to communicate with the researcher

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treatment status
To account for time bias, each subject will be created with two clones at time zero and assigned each of the two clones to either treatment or no-treatment status, respectively. The treatment status in each evaluative endpoint (i.e., 1-month, 4-month, 10-month, and 13-month) is defined as subjects who have received the mapped intervention for the respective length of time since the time zero during which the intervention has just commenced.
Intervention will be conducted to improve lifestyle based on their needs which include 1) Home modification, 2) Lifestyle-based health promotion, 3) Geriatric symptom management, 4) Health counseling for chronic disease management, 5) Counseling-based service, 6) Social network optimization, 7) Social support optimization
No Intervention: No-treatment status
To account for immortal time bias, each subject will be created with two clones at time zero and assigned each of the two clones to either treatment or no-treatment status, respectively. The corresponding no-treatment status is defined as subjects who have not received any mapped intervention for the corresponding length of time.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EuroQoL-5 Dimension-5 Level
Time Frame: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Measuring Health-related quality of life (HRQL) (range from -0.59 to 1.0), higher score indicates better quality of life
Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Short Physical Performance Battery
Time Frame: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Measuring by (range from 0 to 12), with higher score indicating better physical performance
Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
5-minute Montreal Cognitive Assessment (MoCA)
Time Frame: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Measuring Cognitive function (range from 0 to 30), A score of 26 or over is considered to be normal.
Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
7-item Memory Complaint Scale (MCS)
Time Frame: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Measuring Subjective Memory Score (range from 0 to 14), lower score indicates better memory performance. No MCs (0-2), Mild MCs (3-6), Moderate MCs (7-10), Severe MCs (11-14).
Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
3-item University of California, Los Angeles (UCLA) Loneliness Scale
Time Frame: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Measuring Loneliness (range 3-9), higher score indicates greater loneliness.
Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
The 8-item Geriatric Depression Scale
Time Frame: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Measuring Depression (range 0 to 8), with higher score indicating higher risk of depression
Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
8-item Social Connectedness Scale Revised
Time Frame: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Measuring Social connectedness (range 0 to 48), <22 indicates lack of social connectedness
Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health service utilization
Time Frame: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Self-developed checklist on community care service for older adults in Hong Kong
Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Health service utilization
Time Frame: From baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.

Self-developed checklist on health service utilization (including visit to out-patient clinic, emergency medical service, an in-hospital service in private and/or public sectors).

[generic] With the consent from the participants, the above information will be retrieved from the electronic health record. Otherwise, self-report method will be used for collecting the data.

From baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Doris Sau Fung YU, The University of Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 5, 2024

Primary Completion (Estimated)

September 30, 2027

Study Completion (Estimated)

January 31, 2028

Study Registration Dates

First Submitted

December 12, 2025

First Submitted That Met QC Criteria

December 12, 2025

First Posted (Actual)

December 26, 2025

Study Record Updates

Last Update Posted (Actual)

December 26, 2025

Last Update Submitted That Met QC Criteria

December 12, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • REACH & MAP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is not a plan to make individual participant data (IPD) available to other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hard-to-Reach Elderly

Clinical Trials on Mapped intervention based on health status

Subscribe